A detailed history of Patient Square Capital LP transactions in Liquidia Corp stock. As of the latest transaction made, Patient Square Capital LP holds 7,182,532 shares of LQDA stock, worth $79.1 Million. This represents 40.01% of its overall portfolio holdings.

Number of Shares
7,182,532
Previous 7,182,532 -0.0%
Holding current value
$79.1 Million
Previous $106 Billion 18.64%
% of portfolio
40.01%
Previous 45.11%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$11.35 - $16.73 $81.5 Million - $120 Million
7,182,532 New
7,182,532 $106 Billion

Others Institutions Holding LQDA

About Liquidia Corp


  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $709M
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track This Portfolio

Track Patient Square Capital LP Portfolio

Follow Patient Square Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Patient Square Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Patient Square Capital LP with notifications on news.